GZTC may have the most economical way to do that, IMO.
Ralf:
I own a small chunk of this company..........
Tuesday June 5, 8:50 am Eastern Time
Press Release
Epicyte Receives SBIR Grant to Fund HPV Antibody
Development
Marks Fifth Grant for Epicyte to Develop Sexual Health Products
SAN DIEGO--(BW HealthWire)--June 5, 2001--Epicyte Pharmaceutical Inc. today
announced that the Company has been awarded a Phase I Small Business Innovation
Research (SBIR) grant from the National Institutes of Health for the development of
antibodies to prevent the transmission of human papillomavirus (HPV).
The SBIR Advanced Technology grant, valued at $500,000, will help fund Epicyte's product
development and clinical trials for an anti-viral topical microbicide to prevent the sexual
transmission of pathogens. The product will be developed using Epicyte's Plantibodies(TM)
technology for manufacturing human monoclonal antibodies in plants. (snip)
biz.yahoo.com
All other things equal (they aren't!), I'd bet on plants over milk. Keep your head up? If you start to see that GZTC, like Epicyte, is most enthusiastic about topical applications...... run, don't walk, away.
In the interim, I'll share your enthusiasm for GZTC. However, the ATIII story is/was ugly. |
